HIGHLIGHTS
- who: Antal H. Kovacs et al. from the Department of Chemistry, Lakehead University, Oliver Road, Thunder Bay, ON P B , Canada have published the paper: Aurora B Inhibitors as Cancer Therapeutics, in the Journal: Molecules 2023, 3385 of /2023/
- what: The prevalence of cancer is increasing gradually, year by year.
- how: This paper presents a comprehensive review of the preclinical and clinical candidates of potential anticancer drugs.
- future: Derivatives of its structure could offer promising candidates for future studies. Described in 2008 it has entered one clinical trial (Phase I advanced . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.